FDA NDC Directory · JSON-LD · Markdown

DAYVIGO

NDC 62856-405 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Generic namelemborexant
Labeler / ManufacturerEisai Inc.
Marketing categoryNew Drug Application (innovator) · App NDA212028
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsLEMBOREXANT (5 mg/1)
Marketing started20200407
Package count3

External sources

Source: openFDA. Public-domain (CC0).